Baselake Partners, LP - Oct 27, 2025 SCHEDULE 13G Report for Neuphoria Therapeutics Inc. Common Stock, $0.00001 par value per share (NEUP)

Filing Manager
Baselake Partners, LP
Reporting Manager
Baselake Partners, LP
Security
Neuphoria Therapeutics Inc. Common Stock, $0.00001 par value per share
Symbol
NEUP
Shares outstanding
2.36M shares
Disclosed Ownership
222K shares
Ownership
9.4%
Form type
SCHEDULE 13G
Date filed
10/31/2025, 04:31 PM
Date of event
Oct 27, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Baselake Partners, LP 9.4% 222K 0 222K /s/ David Paolella David Paolella, Managing Member of Baselake Management, LLC, its investment manager
Baselake Management, LLC 9.4% 222K 0 222K /s/ David Paolella David Paolella, Managing Member
David Paolella 9.4% 222K 0 222K /s/ David Paolella Individually